Post-Dilatation Effect on TAVI Prostheses Expansion
Effects of Post-Dilatation on Valve Hemodynamics, Durability and Outcome in Balloon-Expandable TAVI Prostheses (The Randomized-Controlled DUOTAP Trial).
Medical University of Vienna
146 participants
Jan 1, 2025
INTERVENTIONAL
Conditions
Summary
Asymmetrical and inadequate expansion of trans-catheter heart valves (THVs) have been described as a key predictor of impaired valve hemodynamic performance predisposing patients for bio-prosthetic valve dysfunction (BVD) and death. Post-dilatation using the original delivery system balloon at the identical filling volume after deployment of balloon-expandable THVs represents an invasive strategy to potentially optimize expansion and reduce asymmetry of balloon-expandable THVs. Currently, the efficacy and safety of routine post-dilatation has never been assessed in a randomized controlled fashion. The present randomized controlled DUO-TAP trial aims to assess efficacy and safety of routine post-dilatation on THV expansion, asymmetry, hemodynamic, durability, and associated clinical outcomes in patients with severe aortic stenosis.
Eligibility
Inclusion Criteria5
- Severe AS
- AS treatment by transfemoral TAVI as determined by an interdisciplinary heart team board
- Anatomical feasibility to receive a balloon-expandable TAVI
- Age 65 years or older
- Subject or guardian agrees to all provisions of the protocol, including the possibility of randomization to the control group and returning for all required post-procedure follow up visits, and has provided written informed consent
Exclusion Criteria6
- Active endocarditis or active rheumatic heart disease or leaflets degenerated from rheumatic disease (i.e., non compliant, perforated)
- Active infections requiring current antibiotic therapy
- Bicuspid aortic valve anatomy
- Pregnant or planning pregnancy within next 12 months
- Severe calcification of the aortic annulus protruding in the left ventricular outflow tract (predisposing for annular rupture)
- Significant coronary artery disease with substantial risk of hemodynamic instability during rapid ventricular pacing
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Nominal post-dilatation using the original delivery balloon
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07477002